Skip to main content
Clinical Trials/NCT06585722
NCT06585722
Recruiting
N/A

The Association Between Venous Excess Ultrasound, the Lung Ultrasound Score and Acute Kidney Injury and Death in the Intensive Care Unit Population

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 site in 1 country136 target enrollmentFebruary 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Fluid Overload
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Enrollment
136
Locations
1
Primary Endpoint
Rate of acute kidney injury
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Fluid resuscitation is one of the cornerstones of treatment in ICU patients. Nonetheless, excessive fluid administration can lead to fluid overload which has been associated with worse outcomes in the ICU. To prevent this, assessments of fluid responsiveness are commonly employed. However, fluid responsiveness does not take fluid tolerance into account. Fluid tolerance is the idea that a patient might still be fluid responsive but might already be at risk of the detrimental effects of fluid therapy. Recent developments in point of care ultrasound e.g. the Venous excess ultrasound might help identify patients at risk of fluid overload. However its association with patient relevant outcomes in the ICU remains unclear.

Detailed Description

This study will investigate the association between the venous excess ultrasound grading system (VExUS) and patient relevant outcomes such as acute kidney injury, mortality and length of stay. A secondary analysis is planned where the association between VExUS and the lung ultrasound score will be investigated

Registry
clinicaltrials.gov
Start Date
February 1, 2023
End Date
September 5, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

P.R. Tuinman

Dr. P.R. Tuinman, Principal Investigator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Eligibility Criteria

Inclusion Criteria

  • all patients admitted to the ICU 18 years or older expected to stay in the ICU for more than 24 hours

Exclusion Criteria

  • any obstruction between the righ atrium and structures assessed by VExUS
  • a medical history of: Major cardiac shunts (e.g. atrial septum defect), Tricuspid regurgitation, dialysis, portal hypertension, pulmonary hypertension, interstitial lung disease, recipients of a kidney of liver transplant.
  • patients in whom an ultrasound assesment is unfeasible e.g. a BMI over 40

Outcomes

Primary Outcomes

Rate of acute kidney injury

Time Frame: within 30 days of admission to the ICU

Clinically relevant acute kidney injury in the ICU: a 200% rise in creatinine or the use of renal replacement therapy

Mortality

Time Frame: within 30 days of admission to the ICU

death of all causes

Rate of MAKE-30

Time Frame: within 30 days of admission to the ICU

a composite endpoint of mortality and acute kidney injury ( including renal replacement therapy)

Study Sites (1)

Loading locations...

Similar Trials